HAP Trading’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-2,542
Closed -$600K 2542
2021
Q3
$629K Buy
2,542
+1,160
+84% +$332K 0.02% 611
2021
Q2
$573K Buy
1,382
+265
+24% +$105K 0.02% 610
2021
Q1
$436K Buy
+1,117
New +$550K 0.02% 531
2020
Q3
Sell
-1,286
Closed -$1M 1592
2020
Q2
$1.02M Buy
1,286
+488
+61% +$368K 0.06% 277
2020
Q1
$475K Sell
798
-652
-45% -$635K 0.03% 351
2019
Q4
$1.65M Buy
+1,450
New +$1.58M 0.09% 146

Other funds holding BLUE

HAP Trading's BLUE Position: Q4 2021 in Review

HAP Trading sold out of bluebird bio (BLUE) in Q4 2021, closing a stake of 2,542 shares — an estimated $600K sold.

HAP Trading first reported a position in BLUE in Q4 2019 and held it in 6 quarters. The position peaked at $1.65M in Q4 2019. 172 funds tracked by Wall St. Rank hold BLUE as of Q4 2021.

  • HAP Trading reported no remaining bluebird bio position as of Q4 2021 after selling out during the quarter.
  • HAP Trading sold 2,542 bluebird bio shares in Q4 2021, an estimated $600K.
  • HAP Trading first reported a position in bluebird bio in Q4 2019 and held it in 6 quarters.
  • HAP Trading's bluebird bio position peaked at $1.65M in Q4 2019.
  • 172 funds tracked by Wall St. Rank held bluebird bio as of Q4 2021.

Based on HAP Trading's 13F filing for Q4 2021, filed 14 Feb 2022.